Smith & Nephew, for a start.
Why? Because there is a growing expectation the US Federal Trade Commission will soon (possibly as early as this week) make up its mind on whether it will give the green light to Zimmer's purchase of rival Biomet for $13.4 billion.
Showing posts with label Stryker. Show all posts
Showing posts with label Stryker. Show all posts
Monday, 15 June 2015
Subscribe to:
Comments (Atom)